SHAREHOLDER ALERT: Kiromic Biopharma, Inc. (KRBP) Officers and Directors Under Investigation for Possible False Statements About Its Commercial Prospects

(marketscreener.com) SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Kiromic Biopharma, Inc. relating to possible false and misleading statements to investors concerning commercial prospects for the company's immunotherapy medications. Kiromic is a target...https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/SHAREHOLDER-ALERT-Kiromic-Biopharma-Inc-KRBP-Officers-and-Directors-Under-Investigation-for-Pos-42242557/?utm_medium=RSS&utm_content=20221108